Literature DB >> 111463

Side-effects of prostaglandin synthetase inhibitors.

K E Andersson.   

Abstract

A short review is given of some of the adverse reactions to prostaglandin synthetase inhibitors. Broadly, these side-effects can be divided into those common to the whole group, and those more or less characteristic of the individual drugs. Among the former, symptoms from the gastrointestinal tract and from the central nervous system are the most conspicuous. Skin reactions, bronchospasm, and serious blood dyscrasias have been reported for several of these drugs and the list of more rare side-effects is long. It is concluded that drugs like phenylbutazone and oxyphenbutazone should not be used for treatment of dysmenorrhea because of the risks of serious adverse reactions. However, even if among the newly introduced compounds none can be said to be free from risks, some seem to have an acceptable ratio between therapeutic efficacy and side-effects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111463     DOI: 10.3109/00016347909157801

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand Suppl        ISSN: 0300-8835


  3 in total

1.  Prostaglandin inhibitors: rational therapy for dysmenorrhea.

Authors:  J Sorbie
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

2.  Efficacy of ketoprofen in treating primary dysmenorrhea.

Authors:  S Gleeson; J Sorbie
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

Review 3.  Molecular aspects of development and regulation of endometriosis.

Authors:  Yana B Aznaurova; Marat B Zhumataev; Tiffany K Roberts; Alexander M Aliper; Alex A Zhavoronkov
Journal:  Reprod Biol Endocrinol       Date:  2014-06-13       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.